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Tumor necrosis factor- α, adiponectin and their ratio in 
gestational diabetes mellitus 
 
 
Abstract 
Background: It has been suggested that inflammation might be implicated in the 
gestational diabetes mellitus (GDM) complications, including insulin resistance. The aims 
of the current study were to explore maternal circulating values of TNF-α, adiponectin and 
the adiponectin/TNF-α ratio in women with GDM compared with normal pregnancy and 
their relationships with metabolic syndrome biomarkers. 
Methods: Forty women with GDM and 40 normal pregnant women were included in the 
study. Commercially available enzyme-linked immunosorbent assay methods were used to 
measure serum levels of TNF-α and total adiponectin. 
Results: Women with GDM had higher values of TNF-α (225.08±27.35 vs 115.68±12.64 
pg/ml, p<0.001) and lower values of adiponectin (4.50±0.38 vs 6.37±0.59 µg/ml, p=0.003) 
and the adiponectin/TNF-α ratio (4.31±0.05 vs 4.80±0.07, P<0.001) than normal pregnant 
women. The adiponectin/TNF-α ratio showed negative correlations with insulin resistance 
(r=-0.68, p<0.001) and triglyceride (r=-0.39, p=0.014) and a positive correlation with 
insulin sensitivity (r=0.69, p<0.001). Multiple linear regression analysis showed that 
values of the adiponectin /TNF-α ratio were independently associated with insulin 
resistance. Binary logistic regression analysis showed that GDM was negatively associated 
with adiponectin /TNF-α ratio. 
Conclusions: In summary, the adiponectin/TNF-α ratio decreased significantly in GDM 
compared with normal pregnancy. The ratio might be an informative biomarker for 
assessment of pregnant women at high risk of insulin resistance and dyslipidemia and for 
diagnosis and therapeutic monitoring aims in GDM. 
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Gestational diabetes mellitus (GDM), which is defined as glucose intolerance with 
onset or first diagnosis during pregnancy, is one of the most important pregnancy 
complications (1-4). It affects approximately 1 to 20% of all pregnancies worldwide and 
its prevalence in Iranian women is about 4 to 9% of all pregnancies (5). It has been 
suggested that inflammation might be implicated in the GDM pathogenesis (6). In recent 
years, the role of pro-inflammatory cytokines such as tumor necrosis factor- α (TNF-α), 
and anti-inflammatory cytokine such as adiponectin has been increasingly studied in GDM 
(4). TNF-α is one of proposed molecules that can cause insulin resistance during 
pregnancy. On the other hand, adiponectin has been suggested as the strongest anti-
inflammatory cytokine that promotes insulin sensitization by stimulating AMP-activated 
protein kinase that leads to increase glucose uptake in skeletal muscle (7, 8). There are 
some conflicting findings of maternal circulating levels of the cytokines in women with 
GDM compared with normal pregnancy (5, 7).  
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Therefore, the aims of the current study were to explore 
maternal circulating values of TNF-α, adiponectin and the 
adiponectin/TNF-α ratio in Iranian women with GDM 
compared with normal pregnancy and their relationships 
with metabolic syndrome biomarkers.  
 
 
Methods 
This case-control study was conducted at the Obstetrics 
and Gynecology Hospital of Lorestan University of Medical 
Sciences (July, 2014- March, 2015) after being approved by 
the Institutional Ethics Review Board. Informed consent was 
obtained from each pregnant woman enrolled in this study. 
The study population consisted of 40 nulliparous women 
with newly diagnosed GDM before any drug treatment, and 
40 normal nulliparous pregnant women at 24-28 weeks of 
gestation. All subjects were Iranian with Lor ethnicity. The 
diagnosis of GDM was made according to the 75-g oral 
glucose tolerance test (OGTT) (9). Exclusion criteria were 
smoking, multiparity, diabetes mellitus, chronic 
hypertension, preeclampsia and the patients who were under 
treatment with metformin or insulin (10). 
Commercially available photometric methods were used 
to measure fasting serum levels of glucose (FBG), total 
cholesterol (TC), triglyceride (TG) (ZiestChem Diagnostic, 
Tehran, Iran) and high-density lipoprotein cholesterol (HDL-
C) (Parsazmun, Karaj, Iran) using a chemistry analyzer 
(Hitachi, Germany). The intra-assay and inter-assay 
coefficients of variation were <10% according to the 
manufacturers. Low-density lipoprotein cholesterol (LDL-C) 
was estimated by Friedewald’s equation (11). The lipid 
ratios including the TC/HDL-C ratio, the LDL-C/HDL-C 
ratio and the TG/TC ratio were calculated (12). The 
atherogenic index of plasma (AIP) was calculated using log 
(TG/HDL-C) formula (13).  
Commercially available enzyme-linked immunosorbent 
assay (ELISA) methods were used to measure serum  levels 
of TNF-α (Ani Biotech Oy, Orgenium Laboratories Business 
Unit, Finland), total adiponectin (BioVendor Laboratory 
Medicine, Inc. Czech Republic) and insulin (Monobind Inc., 
USA) using an ELISA reader (STAT FAX 3200, USA). The 
intra-assay coefficient of variation of all the ELISA assays 
was <10% according to the manufacture. The sensitivities of 
the assays were 15 pg/ml, 26 ng/ml and 0.75µIU/ml, 
respectively, according to the manufacture. The 
adiponectin/TNF-α ratio was calculated and log-transformed.  
Insulin resistance was calculated using the homeostasis 
model assessment of insulin resistance (HOMA-IR) index 
formula (14). The quantitative insulin sensitivity check index 
(QUICKI) was used to estimate insulin sensitivity (15). 
The Kolmogorov–Smirnov test was used to explore the 
normality of distribution of the variables. The Student t-test 
and Pearson’s correlation analysis were used to do statistical 
calculations for quantitative variables with normal 
distributions. Skewed parameters were analyzed by the 
Mann–Whitney U-test and Spearman’s correlation. Multiple 
linear regression analysis was also performed to determine 
the independent predictors of FBG, the HOMA-IR index and 
the QUICKI as the dependent variables. Non-normally 
distributed parameters were log-transformed for the multiple 
linear regression analysis. To assess the risk markers for the 
diagnosis of GDM, a multiple logistic regression analysis 
was performed. A p-value less than 0.05 was considered 
statistically significant. Data are presented as mean±SEM. 
Statistical computations were done using SPSS Version 19 
software. 
 
 
Results 
The demographic and biochemical characteristics of 
women with GDM and normal pregnant women are 
presented in tables 1 and 2. There were no significant 
differences in gestational age (26.25±0.24 vs 26.13±0.22 
weeks, p=0.672) and BMI (27.25±0.18 vs 27.66±0.17 kg/m
2
,
 
p=0.107) between normal pregnant women and patients. 
Though, women with GDM were older than control group 
(31.67±0.54 vs 29.15±0.58, p=0.002).  
Women with GDM had higher values of FBG 
(100.83±1.54 vs 78.45±1.29 mg/dl, p<0.001), the LDL-
C/HDL-C ratio (5.17±0.58 vs 3.23±0.36, p=0.014), the 
TC/HDL-C ratio (7.88±0.65 vs 5.32±0.54, p<0.001), the 
TG/TC ratio (1.17±0.10 vs 0.94±0.06, P=0.046), AIP 
(0.87±0.04 vs 0.63±0.04, p<0.001), insullin (12.56±0.90 vs 
9.54±0.55 µIU/ml, P=0.006), the HOMA-IR index 
(3.11±0.22 vs 1.85±0.11, p<0.001) and TNF-α 
(225.08±27.35 vs 115.68±12.64 pg/ml, p<0.001) than 
normal pregnant women. Although, values of QUICKI 
(0.33±0.01 vs 0.36±0.01, p<0.001), adiponectin (4.50±0.38 
vs 6.37±0.59 µg/ml, P=0.003) and the adiponectin/TNF-α 
ratio (4.31±0.05 vs 4.80±0.07, p<0.001) were significantly 
lower in GDM than in normal pregnancy. Comparisons of 
the values of TNF-α and adiponectin between women with 
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GDM and normal pregnant women remained statistically 
significant after adjusting for maternal age. 
 
Table 1. Demographic characteristics of women with 
gestational diabetes mellitus (GDM) compared with 
normal pregnant women  
 
Parameter Normal 
pregnant 
 (n=51) 
GDM 
(n=49) 
Pvalue 
Age (years) 29.15±0.58 31.67±0.54 0.002 
Gestational age(weeks) 26.25±0.24 26.13±0.22 0.672 
BMI (kg/m
2
) 27.25±0.18 27.66±0.17 0.107 
Data are presented as mean ± SEM. BMI = body mass index.  
 
Table 2. Biochemichal characteristics of  gestational 
diabetes mellitus (GDM) and normal pregnant women.  
Parameter Normal 
pregnant 
(n=40) 
GDM 
(n=40) 
Pvalue 
FBG (mg/dl) 78.45±1.29 100.83±1.54 <0.001 
TG (mg/dl) 221.83±14.00 256.12±19.12 0.236 
TC (mg/dl) 242.67±10.18 225.84±9.88 0.239 
HDL-C (mg/dl) 52.21±2.95 34.70±2.71 <0.001 
LDL-C (mg/dl) 146.10±7.84 139.92±10.11 0.341 
TG/TC ratio 0.94±0.06 1.17±0.10 0.046 
TC/HDL-C ratio 5.32±0.54 7.88±0.65 <0.001 
LDL-C/HDL-C ratio 3.23±0.36 5.17±0.58 0.014 
AIP 0.63±0.04 0.87±0.04 <0.001 
Insullin (µIU/ml) 9.54±0.55 12.56±0.90 0.006 
HOMA-IR 1.85±0.11 3.11±0.22 <0.001 
QUICKI 0.36±0.01 0.33±0.01 <0.001 
Adiponectin (µg/ml) 6.37±0.59 4.50±0.38 0.003 
TNF-α (pg/ml) 115.68±12.64 225.08±27.35 <0.001 
Adiponectin 
/TNF-α ratio 
4.80±0.07 4.31±0.05 <0.001 
Data are presented as mean±SEM.  
FBG= fasting blood glucose, TG= triglyceride, TC= total cholesterol, HDL-
C= high-density lipoprotein cholesterol, LDL-C= low-density lipoprotein 
cholesterol, AIP= atherogenic index of plasma, HOMA-IR= homeostasis 
model assessment of insulin resistance, QUICKI= quantitative insulin 
sensitivity check index, TNF-α= tumor necrosis factor- α 
 
The HOMA-IR index values correlated negatively with 
values of adiponectin (r=-0.45, p=0.004) and the 
adiponectin/TNF-α ratio (r=-0.68, p<0.001) and positively 
with the levels of TNF-α (r=0.60, p<0.001) in normal 
pregnant women (data not shown). The QUICKI showed 
positive correlations with values of adiponectin (r=0.45, 
p=0.004) and the adiponectin/TNF-α ratio (r=0.69, p<0.001) 
and negative correlations with values of TNF-α (r=-0.59, 
p<0.001), the LDL-C/HDL-C ratio (r=-0.31, p=0.048) and 
the TG/TC ratio (r=-0.33, p=0.036) in women with normal 
pregnancy (data not shown). In GDM, values of FBG 
correlated negatively with adiponectin (r=-0.34, p=0.033) 
(data not shown). Values of TG correlated positively with 
the HOMA-IR index (r=0.35, p=0.027) and negatively with 
the QUICKI (r=-0.34, p=0.034), adiponectin (r= -0.42, 
P=0.007) (data not shown) and the adiponectin/TNF-α ratio 
(r=-0.39, p=0.014) (fig. 1) in women with GDM. The TG/TC 
ratio values correlated negatively with adiponectin (r=-0.43, 
p=0.006) and the adiponectin/TNF-α ratio (r=-0.48, p=0.002) 
in GDM (data not shown).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Correlations between values of TG and the 
adiponectin /TNF-α ratio in women with gestational 
diabetes mellitus (r=-0.39, p=0.014). 
 
The correlations were also examined in total subjects of 
entire GDM and normal pregnant women (n=80). Levels of 
adiponectin correlated negatively with values of TNF-α (r=-
0.24, p=0.030), TG (r=-0.35, p=0.002), and the TG/TC ratio 
(r=-0.37, P=0.001) in the pooled sample (data not shown). 
Adiponectin showed slightly negative correlation with AIP 
(r=-0.21, p=0.065). Values of the adiponectin/TNF-α ratio 
showed negative correlations with values of  TG (r=-0.24, 
p=0.030) and the TG/TC ratio (r=-0.29, p=0.011) in the 
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pooled sample (data not shown). In the total sample, serum 
levels of FBG correlated positively with values of TNF-α 
(r=0.51, p<0.001), TG (r=0.22, p=0.048), the TG/TC ratio 
(r=0.26, p=0.018), the TC/HDL-C ratio (r=0.32, p=0.003) 
and AIP (r=0.44, p<0.001) and negatively with values of 
HDL-C (r=-0.40, p<0.001), adiponectin (r=-0.39, p<0.001) 
and the adiponectin/TNF-α ratio (r= -0.54, p<0.001) (data 
not shown). 
 The HOMA-IR index showed positive correlations with 
values of TNF-α (r=0.38, p=0.000), TG (r=0.30, P=0.006), 
the TG/TC ratio (r=0.35, p=0.001) and AIP (r=0.36, 
p=0.001) and negative correlations with values of 
adiponectin (r=-0.38, p<0.001) and the adiponectin/TNF-α 
ratio (r=-0.45, p<0.001) in the pooled sample (data not 
shown). Values of QUICKI correlated negatively with values 
of TNF-α (r=-0.38, p=0.001), TG (r=-0.31, P=0.006), the 
TG/TC ratio (r= -0.35, p=0.001) and AIP (r=-0.36, p=0.006) 
and positively with values of adiponectin (r=0.38, p<0.001) 
and the adiponectin/TNF-α ratio (r=0.45, p<0.001) in the 
pooled sample (data not shown).  
Multiple linear regression analysis with FBG, the 
HOMA-IR index and the QUICKI as the dependent variables 
and all the variables that showed statistically significant 
correlations with them in the univariate analysis were also 
performed. In this model, values of the adiponectin /TNF-α 
ratio were independently associated with FBG (β=- 0.46, 
p<0.001), the HOMA-IR index (β=- 1.54, p=0.003) and the 
QUICKI (β=0.37, p=0.001). 
 The risk markers for the diagnosis of GDM were 
assessed using binary logistic regression analysis. Univariate 
binary logistic regression analysis for lipid profile, the lipid 
ratios, adiponectin, TNF-α and the adiponectin/TNF-α ratio 
showed that the LDL-C/HDL-C ratio, the TC/HDL-C ratio, 
AIP and TNF-α were positive risk markers for GDM 
development while HDL-C, adiponectin and the 
adiponectin/TNF-α ratio might have protective effects. A 
multiple binary logistic regression analysis with the lipid 
ratios, AIP and HDL-C showed that AIP was indepently a 
risk marker for GDM development. 
 A multiple binary logistic regression analysis for 
adiponectin, TNF-α and the adiponectin/TNF-α ratio showed 
that the ratio was indepently a negative risk marker for GDM 
development. A multiple binary logistic regression analysis 
for AIP and the adiponectin/TNF-α ratio showed that AIP 
was indepently a risk marker for GDM development while 
the adiponectin/TNF-α ratio had protective effects (table 3).  
Table 3. Multiple binary logistic regression analysis of 
the effects of AIP and Log (adiponectin /TNF-α) on 
gestational diabetes mellitus.  
 
Variables B OR 95% CI for OR pvalue 
AIP 3.67 39.18 3.963–387.363 0.002 
Adiponectin 
 /TNF-α ratio 
- 4.72 0.009 0.001–0.122 <0.001 
CI confidence interval, OR, odds ratio, Other abbreviations are 
given in Table 1 
 
Discussion 
The main findings of the present study were a 
significantly lower level of the adiponectin/TNF-α ratio in 
GDM compared with normal pregnancy and significant 
associations of the ratio with metabolic syndrome 
biomarkers. There are some conflicting findings of maternal 
circulating levels of the cytokines adiponectin and TNF-α in 
women with GDM compared with normal pregnant women 
and their associations with metabolic syndrome biomarkers. 
López-Tinoco et al. (16) and Liu et al.’s (17) studies showed 
that levels of adiponectin decreased and levels of TNF-α 
increased significantly in GDM compared with normal 
pregnancy. In Liu et al.’s study, the HOMA-IR index values 
have been negatively associated with adiponectin and 
positively with TNF-α. (17). These findings were confirmed 
by the current study . On the other hand, Kim et al. showed 
that the maternal serum levels of total adiponectin in GDM 
are significantly lower than normal pregnancy, while the 
levels of TNF-α do not change significantly between two 
groups (18).  
In another study in Tunisia, women with GDM have 
higher values the HOMA-IR index and lower levels of 
adiponectin than normal pregnant women, but levels of 
TNF-α do not differ significantly between two groups (19). 
A study in Iranian pregnant women showed that values of 
adiponetin, the TG/HDL-C ratio and QUICKI do not change 
significantly between GDM and normal pregnancy while 
HOMA-IR index values increased in GDM (5). A systematic 
review study by Gomes et al. reported that women with 
GDM in the 3rd trimester of pregnancy have slightly higher 
values of TNF-α than normal pregnancy. They proposed that 
several factors, including gestational age, ethnicity, smoking 
and BMI could influence cytokine production during 
pregnancy. Therefore, patients and normal control women 
should be matched for BMI and gestational age and their 
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smoking habits and ethnicity should be clarified in the 
studies (6). It has been proposed that adiponectin has anti-
inflammatory properties by suppressing TNF-α gene 
transcription (20). The indirect correlation observed between 
these cytokines in the current study might be addressed by 
this proposed mechanism. It has also been proposed that 
TNF-α increasing in GDM can suppress transcription of 
adiponectin that results in insulin resistance and 
hyperinsulinemia (21). Therefore, significantly decreased 
adiponectin/TNF-α ratio could lead to some important 
metabolic complications that were shown in the current 
study.  
The ratio showed negative correlations with insulin 
resistance, TG and the TG/TC ratio and positive correlation 
with insulin sensitivity in the current study. Although many 
important physiological functions have been addressed to 
adiponectin, it is not vital to life under normal conditions. 
Desoite that the role of the cytokine will be essential under 
hyperglycemic and dyslipidemic situations. On the other 
hand, certain diabetes drugs that decrease insulin resistance 
only work in the presence of the cytokine. Systemic highly 
lipotoxic environment due to severe hyperlipidemia –the 
common process in types 1 and 2 diabetes –is toxic for beta 
cells. Adiponectin stimulate lipid storage in adipocytes 
which may contribute, at least in part, to the reduction of 
beta cells lipotoxicity (22).  
Study of Li et al. showed that adipose tissue partly 
regulates hepatic cholesterol metabolism via adiponectin. 
They developed a co-culture system of adipocytes and 
hepatocytes to study the interaction between these two cell 
types. They observed that adiponectin can decrease activity 
of 3-hydroxy-3-methyl-glutaryl-CoA reductase ( HMGR), a 
key enzyme in cholesterol biosynthesis pathway, and 
increase expression of ATP-binding cassette transporter A1 
(ABCA1) which plays a crucial role in the efflux of cellular 
cholesterol to HDL (23).   
An intervention study conducted by Aye et al. in a mouse 
model of obesity in pregnancy shows that using synthetic 
adiponectin receptor agonist may be a helpful intervention 
treatment to increase functional adiponectin on maternal and 
placental tissues to reduce the metabolic and hormonal 
complications due to maternal obesity and GDM (24). It has 
been shown that, in contrast to adiponectin, TNF-α 
stimulates amino acid transport in primary human 
trophoblasts through system A transporter (25). Thus, 
normalization of adiponectin can attenuate TNF-α activity.  
According to the available data, it could be concluded 
that adiponectin might be the most important cytokine in the 
regulation of inflammatory and metabolic syndrome status in 
GDM. An indirect correlation observed between adiponectin 
and TNF-α in the current study could be addressed that 
hypoadiponectinemia in GDM results in increased levels of 
TNF-α (21). Adiponectin infusion in pregnant mice results in 
a significant decrease in maternal values of leptin and insulin 
(24). Hence, hypoadiponectinemia leads to hyperleptinemia 
and hyperinsulinemia that could be addressed as increased 
insulin resistance. Consequently, the negative correlations of 
adiponectin and the adiponectin/TNF-α ratio with FBG and 
TG that observed in the current study could be addressed as 
the protective effects of adiponectin against metabolic 
syndrome complications in women with GDM. Adiponectin 
decreases placental system A activity that leads to decreasing 
amino acid transportation to fetus. As a consequenc,  
adiponectin attenuates the effects of TNF-α and interlukin-10 
on fetus (25). On the contrary the adiponectin/TNF-α ratio 
decreased in GDM and showed a negative correlation with 
insulin resistance.  
The major limitations of the current study were: (i) small 
sample size; (ii) the groups did not match for age; and (iii) 
the study designed as a case-control should be designed as a 
cohort study for exploring the adiponectin/TNF-α ratio 
importance as a possible marker in GDM. 
In conclusion, the adiponectin/TNF-α ratio might be 
more informative than diponectin and TNF-α alone for 
predicting women with high risk of insulin resistance and 
metabolic syndrome in pregnancy. The adiponectin /TNF-α 
ratio could be introduced as a possible negative risk factor of 
GDM that might be useful for diagnosis and/or therapeutic 
monitoring aims. Nonetheless, further cohort studies with 
higher sample size might be required for exploring the ratio 
importance in GDM.  
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